Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review

Cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies target the underlying cause of cystic fibrosis (CF), and are generally well-tolerated; however, real-world studies indicate the frequency of discontinuation and adverse events (AEs) may be higher than what was observed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Dagenais, Renée V. E., Su, Victoria C., Quon, Bradley S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795777/
https://www.ncbi.nlm.nih.gov/pubmed/33374882
http://dx.doi.org/10.3390/jcm10010023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795777/
https://www.ncbi.nlm.nih.gov/pubmed/33374882
http://dx.doi.org/10.3390/jcm10010023

Ejemplares similares